Global and United States Cox-2 Inhibitors Market Report & Forecast 2023-2028

Report ID: 1871736 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Cox-2 Inhibitors Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Cox-2 Inhibitors Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Cox-2 Inhibitors Market Size for the Year 2017-2028
        1.2.2 Global Cox-2 Inhibitors Market Size for the Year 2017-2028
    1.3 Cox-2 Inhibitors Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Cox-2 Inhibitors in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Cox-2 Inhibitors Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Cox-2 Inhibitors Market Dynamics
        1.4.1 Cox-2 Inhibitors Industry Trends
        1.4.2 Cox-2 Inhibitors Market Drivers
        1.4.3 Cox-2 Inhibitors Market Challenges
        1.4.4 Cox-2 Inhibitors Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Cox-2 Inhibitors by Type
    2.1 Cox-2 Inhibitors Market Segment by Type
        2.1.1 Selective Cox-2 Inhibitors
        2.1.2 Non Selective Cox-2 Inhibitors
    2.2 Global Cox-2 Inhibitors Market Size by Type (2017, 2022 & 2028)
    2.3 Global Cox-2 Inhibitors Market Size by Type (2017-2028)
    2.4 United States Cox-2 Inhibitors Market Size by Type (2017, 2022 & 2028)
    2.5 United States Cox-2 Inhibitors Market Size by Type (2017-2028)
3 Cox-2 Inhibitors by Application
    3.1 Cox-2 Inhibitors Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Cox-2 Inhibitors Market Size by Application (2017, 2022 & 2028)
    3.3 Global Cox-2 Inhibitors Market Size by Application (2017-2028)
    3.4 United States Cox-2 Inhibitors Market Size by Application (2017, 2022 & 2028)
    3.5 United States Cox-2 Inhibitors Market Size by Application (2017-2028)
4 Global Cox-2 Inhibitors Competitor Landscape by Company
    4.1 Global Cox-2 Inhibitors Market Size by Company
        4.1.1 Top Global Cox-2 Inhibitors Companies Ranked by Revenue (2021)
        4.1.2 Global Cox-2 Inhibitors Revenue by Player (2017-2022)
    4.2 Global Cox-2 Inhibitors Concentration Ratio (CR)
        4.2.1 Cox-2 Inhibitors Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Cox-2 Inhibitors in 2021
        4.2.3 Global Cox-2 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Cox-2 Inhibitors Headquarters, Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Cox-2 Inhibitors Headquarters and Area Served
        4.3.2 Global Cox-2 Inhibitors Companies Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Cox-2 Inhibitors Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Cox-2 Inhibitors Market Size by Company
        4.5.1 Top Cox-2 Inhibitors Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Cox-2 Inhibitors Revenue by Players (2020, 2021 & 2022)
5 Global Cox-2 Inhibitors Market Size by Region
    5.1 Global Cox-2 Inhibitors Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Cox-2 Inhibitors Market Size by Region (2017-2028)
        5.2.1 Global Cox-2 Inhibitors Market Size by Region: 2017-2022
        5.2.2 Global Cox-2 Inhibitors Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Cox-2 Inhibitors Market Size YoY Growth 2017-2028
        6.1.2 North America Cox-2 Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Cox-2 Inhibitors Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Cox-2 Inhibitors Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Cox-2 Inhibitors Market Size YoY Growth 2017-2028
        6.3.2 Europe Cox-2 Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Cox-2 Inhibitors Market Size YoY Growth 2017-2028
        6.4.2 Latin America Cox-2 Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Cox-2 Inhibitors Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Cox-2 Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Company Details
        7.1.2 Bayer Business Overview
        7.1.3 Bayer Cox-2 Inhibitors Introduction
        7.1.4 Bayer Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.1.5 Bayer Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Cox-2 Inhibitors Introduction
        7.2.4 Novartis Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Company Details
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Cox-2 Inhibitors Introduction
        7.3.4 Pfizer Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.3.5 Pfizer Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Cox-2 Inhibitors Introduction
        7.4.4 Merck Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 Cadila Pharmaceuticals
        7.5.1 Cadila Pharmaceuticals Company Details
        7.5.2 Cadila Pharmaceuticals Business Overview
        7.5.3 Cadila Pharmaceuticals Cox-2 Inhibitors Introduction
        7.5.4 Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.5.5 Cadila Pharmaceuticals Recent Development
    7.6 Sabinsa Corporation
        7.6.1 Sabinsa Corporation Company Details
        7.6.2 Sabinsa Corporation Business Overview
        7.6.3 Sabinsa Corporation Cox-2 Inhibitors Introduction
        7.6.4 Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2017-2022)
        7.6.5 Sabinsa Corporation Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Cox-2 Inhibitors Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Cox-2 Inhibitors Market Trends
    Table 3. Cox-2 Inhibitors Market Drivers
    Table 4. Cox-2 Inhibitors Market Challenges
    Table 5. Cox-2 Inhibitors Market Restraints
    Table 6. Global Cox-2 Inhibitors Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Cox-2 Inhibitors Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Cox-2 Inhibitors Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Cox-2 Inhibitors Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Cox-2 Inhibitors Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Cox-2 Inhibitors Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Cox-2 Inhibitors Revenue Share by Player, 2017-2022
    Table 13. Global Cox-2 Inhibitors Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Cox-2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cox-2 Inhibitors as of 2021)
    Table 15. Top Players of Cox-2 Inhibitors in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Cox-2 Inhibitors Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Cox-2 Inhibitors Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Cox-2 Inhibitors Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Cox-2 Inhibitors Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Cox-2 Inhibitors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Cox-2 Inhibitors Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Cox-2 Inhibitors Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Cox-2 Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Cox-2 Inhibitors Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Cox-2 Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Cox-2 Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Cox-2 Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bayer Company Details
    Table 31. Bayer Business Overview
    Table 32. Bayer Cox-2 Inhibitors Product
    Table 33. Bayer Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 34. Bayer Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Cox-2 Inhibitors Product
    Table 38. Novartis Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Pfizer Company Details
    Table 41. Pfizer Business Overview
    Table 42. Pfizer Cox-2 Inhibitors Product
    Table 43. Pfizer Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Cox-2 Inhibitors Product
    Table 48. Merck Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. Cadila Pharmaceuticals Company Details
    Table 51. Cadila Pharmaceuticals Business Overview
    Table 52. Cadila Pharmaceuticals Cox-2 Inhibitors Product
    Table 53. Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 54. Cadila Pharmaceuticals Recent Development
    Table 55. Sabinsa Corporation Company Details
    Table 56. Sabinsa Corporation Business Overview
    Table 57. Sabinsa Corporation Cox-2 Inhibitors Product
    Table 58. Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2017-2022) & (US$ Million)
    Table 59. Sabinsa Corporation Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Cox-2 Inhibitors Product Picture
    Figure 2. Global Cox-2 Inhibitors Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Cox-2 Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 4. United States Cox-2 Inhibitors Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Cox-2 Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 6. United States Cox-2 Inhibitors Market Share in Global 2017-2028
    Figure 7. Cox-2 Inhibitors Report Years Considered
    Figure 8. Product Picture of Selective Cox-2 Inhibitors
    Figure 9. Product Picture of Non Selective Cox-2 Inhibitors
    Figure 10. Global Cox-2 Inhibitors Market Share by Type in 2022 & 2028
    Figure 11. Global Cox-2 Inhibitors Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Cox-2 Inhibitors Market Share by Type (2017-2028)
    Figure 13. United States Cox-2 Inhibitors Market Share by Type in 2022 & 2028
    Figure 14. United States Cox-2 Inhibitors Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Cox-2 Inhibitors Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital Pharmacies
    Figure 17. Product Picture of Retail Pharmacies
    Figure 18. Product Picture of Online Pharmacies
    Figure 19. Global Cox-2 Inhibitors Market Share by Application in 2022 & 2028
    Figure 20. Global Cox-2 Inhibitors Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Cox-2 Inhibitors Market Share by Application (2017-2028)
    Figure 22. United States Cox-2 Inhibitors Market Share by Application in 2022 & 2028
    Figure 23. United States Cox-2 Inhibitors Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Cox-2 Inhibitors Market Share by Application (2017-2028)
    Figure 25. North America Cox-2 Inhibitors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Cox-2 Inhibitors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Cox-2 Inhibitors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Cox-2 Inhibitors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Cox-2 Inhibitors Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Cox-2 Inhibitors Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Bayer Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 54. Novartis Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 55. Pfizer Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 56. Merck Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 57. Cadila Pharmaceuticals Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 58. Sabinsa Corporation Revenue Growth Rate in Cox-2 Inhibitors Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
Frequently Asked Questions
Cox-2 Inhibitors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cox-2 Inhibitors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cox-2 Inhibitors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bridge Cable Sockets

Bridge Cable Sockets market is segmented by region (country), players, by Type and by Application ... Read More

Galvanized Strand

Galvanized Strand market is segmented by region (country), players, by Type and by Application. P ... Read More